Spring 2017

Document Type

Poster Session




Lisa Dietrich


Up until this point research has only focused on angiogenic activators and ineffective growth factor administration Focusing on the angiogenic switch and the use of a bioresorbable stent coated with angiogenic growth factors and anti-inhibitors for prolonged local administration would solve the problems with dosage and controlled release that could push therapeutic angiogenesis over the edge as an extremely effective treatment for cardiovascular disease

Start Date

April 2017



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.